Skip to main content
SpringerLink
Log in

Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat

  • Original Articles
  • Melphalan, Chlorambucil, Ambucil, Pharmacokinetics, Plasma, Brain
  • Published:
Cancer Chemotherapy and Pharmacology Aims and scope Submit manuscript

Summary

Equimolar doses of chlorambucil and melphalan (both 10 mg/kg) were administered i.v. to anesthetized rats, and the plasma and brain concentrations of chlorambucil, its metabolites 3,4-dehydrochlorambucil and phenylacetic mustard, and melphalan were determined by high-performance liquid chromatography from 5 to 240 min therafter. Chlorambucil demonstrated a monophasic disappearance from plasma, with a half-life of 26 min. The compound was 99.6% plasma-protein-bound. Chlorambucil underwent β-oxidation to yield detectable concentrations of 3,4-dehydrochlorambucil and substantial amounts of phenylacetic mustard in the plasma. Low concentrations of chlorambucil and phenylacetic mustard were detected in the brain. Calculated from the areas under the concentration-time curves, the brain: plasma concentration integral ratios of chlorambucil and phenylacetic mustard were 0.021 and 0.013, respectively. Melphalan demonstrated a biphasic disappearance from plasma, with half-lives of 1.9 and 78 min. The compound was approximately 86% plasma protein-bound. Low concentrations of melphalan were detected in the brain, and its brain: plasma ratio was 0.13. These data demonstrate that following the administration of chlorambucil and melphalan, only low concentrations of active drug are able to enter the brain. As a consequence, concentrations of both drugs that cause the complete inhibition of extracerebrally located tumor have no effect on those located within the brain. Further, the brain uptake of melphalan, although low, is greater than that of chlorambucil and its active metabolites, which coincides with its slightly greater intracerebral activity following the systemic administration of very high doses.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Adair C, McElnay J (1986) Studies on the mechanism of gastrointestinal absorption of melphalan and chlorambucil. Cancer Chemother Pharmacol 17: 95–98

    Google Scholar 

  2. Alberts D, Chang S, Chen S, Moon T, Evans T, Furner R, Himmelstein J (1979) Kinetics of intravenous melphalan. Clin Pharmacol Ther 26: 73–80

    Google Scholar 

  3. Begleiter A, Lam H, Grover J, Froese E, Goldenberg G (1979) Evidence for active transport of melphalan by amino acid carriers in L5178Y lymphoblasts in vitro. Cancer Res 39: 353–359

    Google Scholar 

  4. Bosanquet A, Gilbey E (1982) Pharmacokinetics of oral and intravenous melphalan during routine treatment of multiple myeloma. Eur J Cancer Clin Oncol 18: 355–362

    Google Scholar 

  5. Bosanquet A, Gilbey E (1984) Comparison of fed and fasting states on the absorption of melphalan in multiple myeloma. Cancer Chemother Pharmacol 12: 183–186

    Google Scholar 

  6. Byrne T, Moseley T, Finer M (1981) Myoclonic seizures following chlorambucil overdose. Ann Neurol 9: 191–194

    Google Scholar 

  7. Chirigos M, Mead J (1964) Experiments on determination of melphalan by fluorescence. Interaction protein and various solutions. Anal Biochem 7: 259–268

    Google Scholar 

  8. Cornbleet M, Leonard R, Smyth J (1984) High-dose agent therapy: A review of clinical experiences. Cancer Drug Deliv 1: 227–238

    Google Scholar 

  9. Dorr R, Fritz W (1980) Cancer chemotherapy handbook. Kimpton, London

    Google Scholar 

  10. Enck R, Bennett J (1977) Inadvertent chlorambucil overdose in adult. NY State J Med 77: 1480–1481

    Google Scholar 

  11. Ehrsson H, Lonroth U, Wallin I, Ehrnebo M, Nilsson S (1981) Degradation of chlorambucil in aqueous solution — influence of human albumin binding. J Pharm Pharmacol 33: 313–315

    Google Scholar 

  12. Ehrsson T, Lonroth U (1982) Degradation of melphalan in aqueous solutions — influence of human albumin binding. J Pharm Sci 71: 826–828

    Google Scholar 

  13. Fasman G (1976) CRC Handbook of biochemistry and molecular biology, 3rd edn, vol 1. CRC Press, Cleveland, p 319

    Google Scholar 

  14. Fisher B, Carbone P, Economons S (1975) L-Phenylalanine mustard in the management of primary breast cancer. N Engl J Med 292: 117–122

    Google Scholar 

  15. George R, Doth J, Duncan G (1977) Multiple myeloma intermittent combination chemotherapy compared to continuous therapy. Cancer 29: 1665–1670

    Google Scholar 

  16. Godeneche D, Madelmont J, Sauvezie B, Billaud A (1975) Etude de la cinetique d'absorption, de distribution et d'elimination de l'acide N,N-dichloro-2-ethyl-p-amino-phenyl-4, butyrique (chloraminophene) marque au 14C chez le rat. Biochem Pharmacol 24: 1303–1308

    Google Scholar 

  17. Godeneche D, Madelmont J, Moreau M, Plagne R, Meyniel G (1980) Comparative physico-chemical properties, biological effects, and disposition in mice of four nitrogen mustards. Cancer Chemother Pharmacol 5: 1–9

    Google Scholar 

  18. Goldenberg G, Lam H, Begleiter A (1979) Active carrier-mediated transport of melphalan by two separate amino acid transport systems in LPC-1 plasmacytoma cells in vitro. J Biol Chem 254: 1057–1064

    Google Scholar 

  19. Goodman G, Mclean A, Alberts D, Chang S (1982) Inhibition of human tumor clonogenicity by chlorambucil and its metabolites. Br J Cancer 45: 621

    Google Scholar 

  20. Green A, Naiman J (1968) Chlorambucil poisoning. Am J Dis Child 116: 190–191

    Google Scholar 

  21. Greig N (1984) Chemotherapy of brain metastases: current status. Cancer Treat Rev 11: 157–186

    Google Scholar 

  22. Greig N (1987) Brain tumors and the blood-tumor barrier. In: Neuwelt E (ed) The clinical impact of the blood-brain barrier and its manipulation, vol 2. Plenum, New York

    Google Scholar 

  23. Greig N (1987) Optimizing drug delivery to brain tumors. Cancer Treat Rev 14: 1–28

    Google Scholar 

  24. Greig N, Sweeney D (1987) Drug delivery to the brain by blood-brain barrier circumvention and drug modification. In: Neuwelt E (ed) The clinical impact of the blood-brain barrier and its manipulation, vol 1. Plenum, New York

    Google Scholar 

  25. Greig N, Momma S, Sweeney D, Smith Q, Rapoport S (1987) Facilitated transport of melphalan at the rat blood-brain barrier by the large neutral amino acid carrier system. Cancer Res 47: 1571–1576

    Google Scholar 

  26. Greig N, Sweeney D, Rapoport S (1987) Melphalan concentration dependent plasma protein binding in healthy humans and rats. Eur J Clin Pharmacol 32: 179–185

    Google Scholar 

  27. Hill B (1972) Studies on the transport and cellular distribution of chlorambucil in the Yoshida ascites sarcoma. Biochem Pharmacol 21: 495–502

    Google Scholar 

  28. Hill B, Riches P (1971) The absorption, distribution and excretion of 3H-chlorambucil in rats bearing Yoshida ascites sarcoma. Br J Cancer 15: 831–836

    Google Scholar 

  29. Idestrom K, Kimbey E, Bjorkholm M, Mellstedt H, Wahlby S (1982) Treatment of chronic lymphocytic leukaemia and well differentiated lymphoma with continuous low- or intermittent high-dose prednimustine versus chlorambucil prednisolone. Eur J Clin Oncol 18: 1117

    Google Scholar 

  30. Johnstone R, Scholefield P (1965) Amino acid transport into tumor cells. Adv Cancer Res 9: 143–226

    CAS  PubMed  Google Scholar 

  31. Knott G (1979) M-LAB, a mathematical modeling tool. Comput Prog Biomed 10: 271–280

    Google Scholar 

  32. Marquardt D (1963) An algorithm for least squares estimation of nonlinear parameters. J Soc Ind Appl Math 11: 431–441

    MATH  Google Scholar 

  33. Martin B (1965) Potential effect of the plasma protein on drug distribution. Nature 207: 274–276

    Google Scholar 

  34. Martin A, Beer R, Bosanquet A, Gilbey E (1982) The effect of alkylating agents and other drugs on the accumulation of melphalan by murine L1210 leukemia cells in vitro. Biochem Pharmacol 31: 2727–2732

    Google Scholar 

  35. McLean A, Newell D, Baker G (1976) The metabolism of chlorambucil. Biochem Pharmacol 23: 2331

    Google Scholar 

  36. McLean A, Woods R, Catovsky D, Farmer P (1979) Pharmacokinetics and metabolism of chlorambucil in patients with malignant disease. Cancer Treat Rev 6 [Suppl]: 33–42

    Google Scholar 

  37. Miller R (1966) Simultaneous statistical inference. McGraw-Hill, New York, pp 76–81

    Google Scholar 

  38. Mitoma C, Onodera T, Takegoshi T, Thomas D (1977) Metabolic disposition of chlorambucil in rats. Xenobiotica 7: 205–220

    Google Scholar 

  39. Neame K (1968) A comparison of the transport systems for amino acids in brain, intestine, kidney and tumour. Prog Brain Res 29: 185–196

    Google Scholar 

  40. Newell D, Hart L, Harap K (1979) Estimation of chlorambucil, phenylacetic mustard and prednimustine in human plasma by high-performance liquid chromatography. J Chromatogr 164: 114

    Google Scholar 

  41. Oxender D, Christensen H (1963) Distinct mediating systems for the transport of neutral amino acids by the Ehrlich cell. J Biol Chem 28: 3686–3699

    Google Scholar 

  42. Piver M, Barlow J, Lee F (1975) Sequential therapy for advanced ovarian adenocarcinoma: operation, chemotherapy, second-look laparotomy and radiation therapy. Am J Obstet Gynecol 122: 355–357

    Google Scholar 

  43. Rapoport S (1976) Blood-brain barrier in physiology and medicine. Raven, New York

    Google Scholar 

  44. Rosin R, Westbury G (1980) Isolated limb perfusion for malignant melanoma. Practitioner 224: 1031–1036

    Google Scholar 

  45. Sawitsky A, Rai K, Glidewell O, Silver R (1977) Comparison of daily versus intermittent chlorambucil and prenisone therapy in the treatment of patients with chronic lymphocytic leukaemia. Blood50: 1049

    Google Scholar 

  46. Sweeney D, Greig N, Rapoport S (1985) High-performance liquid chromatography analysis of melphalan in plasma, brain and peripheral tissues by o-phthaladehyde derivatization and fluorescence detection. J Chromatogr 339: 434–439

    Google Scholar 

  47. Thomas E, Christensen H (1971) Nature of the cosubstrate action of Na+ and neutral amino acids in a transport system. J Biol Chem 246: 1682–1688

    Google Scholar 

  48. Vistica D (1983) Cellular pharmacokinetics of the phenylalanine mustards. Pharmacol Ther 22: 379–405

    Google Scholar 

  49. Vistica D, Toal J, Rabinovitz M (1978) Characterization of melphalan transport and correlation of uptake with cytotoxicity in cultured L1210 murine leukemia cells. Biochem Pharmacol 27: 2865–2870

    Google Scholar 

  50. Wade L, Katzman R (1975) Synthetic amino acids and the nature of L-DOPA transport at the blood-brain barrier. J Neurochem 25: 837–842

    Google Scholar 

  51. Wolfson S, Olney M (1957) Accidental ingestion of a toxic dose of chlorambucil. J Am Med Assoc 165: 239–240

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Laboratory of Neurosciences, National Institute on Aging, National Institutes of Health, 20892, Bethesda, MD, USA

    Nigel H. Greig, Daniel J. Sweeney & Stanley I. Rapoport

Authors
  1. Nigel H. Greig
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Daniel J. Sweeney
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stanley I. Rapoport
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Greig, N.H., Sweeney, D.J. & Rapoport, S.I. Comparative brain and plasma pharmacokinetics and anticancer activities of chlorambucil and melphalan in the rat. Cancer Chemother. Pharmacol. 21, 1–8 (1988). https://doi.org/10.1007/BF00262729

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00262729

Keywords

Search

Navigation